£3.63m
+18%vs Jun 2024Active07297580Private limited companyNottingham
STANNINGLEY PHARMA LIMITED
Significant control: Imran Khan (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Stanningley Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Stanningley Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
STANNINGLEY PHARMA LIMITED is an active private limited company (company number 07297580) incorporated on 28 June 2010, registered in Nottingham. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 30 June 2025, showing net assets of £3.63m and cash of £1.42m, with 12 employees on average. Net assets rose 18% on the prior period (£3.08m).
Peer position · net assets
By net assets it sits in the top quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
02
Ownership and control
- Mr Imran Khan
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 June 201016 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 12 July 2027in 259 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.42m
+42%vs Jun 2024Not reported
12
+20%vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £3.63m | £1.42m | £1.21m | £706k | — | — | 12 |
| 30 June 2024 | £3.08m | £1000k | £913k | £637k | — | — | 10 |
Current ratio5.69Current assets ÷ creditors within one year
Cash per employee£118kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £3,627,791 at 30 June 2025
- Net assets up 10% or more on the prior period+17.9% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.69
- Cash at bank of £50,000 or moreCash £1,420,264
- Incorporated five or more years agoIncorporated 28 June 2010
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 259 days
- Next accounts duein 155 days
- Accounts period endNet assets £3.63m · small accounts
- Accounts period endNet assets £3.08m · small accounts
- Incorporated
08
Similar companies in Nottingham
- APOLLO MEDICAL TECHNOLOGIES LTDSouthwell · inc. Feb 2010
- VALUPHARM UK LIMITEDNottingham · inc. Feb 2013
- INDEPENDENCE PRODUCTS LTDNottingham · inc. Sept 2006
- GHC MEDICAL LTDNottingham · inc. Jun 2015
- EMPIRE PROMOTIONS LTDNottingham · inc. Jun 2015
- KELPHARMA LTDNewark · inc. Nov 2015
All companies incorporated on 28 June 2010 · in Jun 2010.
09
Reminders for STANNINGLEY PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.